Back to matchesWe found a matchYour institution may have rights to this item. Sign in to continue.TitleATEZOLIZUMAB + OBINUTUZUMAB + VENETOCLAX IN PATIENTS WITH RELAPSED OR REFRACTORY MARGINAL ZONE LYMPHOMA: PRIMARY ANALYSIS OF A PHASE 2 TRIAL FROM LYSA.AuthorsHerbaux, C.; Schiano de Colella, J. M.; Thieblemont, C.; Guidez, S.; Ysebaert, L.; Tilly, H.; Le Gouill, S.; Houot, R.; Bachy, E.; Laurent, C.; Damaj, G.; Feugier, P.; Morineau, N.; Tarte, K.; Morschhauser, F.; Cartron, G.PublicationHematological Oncology, 2021, Vol 39, p1ISSN0278-0232Publication typeArticleDOI10.1002/hon.57_2880